Contrary to its pathological roles in diseases other than cancer, activated GSK3β counters pro-oncogenic pathways such as those mediated by Wnt/β-catenin, Hedgehog, and Notch signaling and transcription factors (e.g., snail) that induce EMT in normal cells. This evidence concerns the gene GSK3B and cancer.